A double blind randomised parallel group multicentre study to assess the clinical safety and efficacy of PAI-2 applied topically for a period of 3 months for the treatment of venous leg ulcers

  • Stacey, Michael, (Chief Investigator)
  • Mcmullin, G (Chief Investigator)
  • Mclellan, D. (Chief Investigator)
    StatusFinished
    Effective start/end date1/01/9831/12/98

    Funding

    • Biotech International Ltd